Laboratory Studies Because the signs and symptoms of coronavirus disease 2019 (COVID-19) may overlap with those of other respiratory pathogens, it is important to perform laboratory testing to specifically identify symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, it is estimated that up to 40% of people with SARS-CoV-2 infection […]
Read More
Better understanding is essential for health system planning Over 530 million people worldwide are estimated to have had covid-19 by June 2022, resulting in more than 6.3 million deaths.1 Although most people have few symptoms or mild to moderate illness, a substantial minority are at higher risk of more severe disease […]
Read More
U.S. Food and Drug Administration advisers say Moderna’s COVID-19 vaccine is safe and effective for children aged 6 months to 17 years, according to an FDA document made public on Friday. Two doses of the Moderna vaccine caused an immune response in clinical trial participants that was similar to the immune response […]
Read More
By testing for both SARS-CoV-2 spike and nucleocapsid antibodies, seroprevalence studies can estimate the proportion of a population with antibodies from previous infection (nucleocapsid antibody or infection-induced seroprevalence) and from infection or vaccination (spike antibody or combined infection- and vaccine-induced seroprevalence). US seroprevalence from July 2020 to May 2021 based […]
Read More
The coronavirus death rate for white Americans has surpassed the rates for Black, Latino, and Asian Americans, according to a new report from The New York Times. Early in the pandemic, the virus had a disproportionate toll on Black and Latino Americans. During the initial months in 2020, the per capita death rate […]
Read More
Créditos: Comité científico Covid
Read More
Summary What is already known about this topic? American Indian or Alaska Native (AI/AN) persons across the United States face substantial health disparities, including a disproportionate incidence of COVID-19 illness. What is added by this report? AI/AN persons living in Alaska are at increased risk for COVID-19 illness, COVID-19–associated hospitalization, […]
Read More
NUEVA ORLEÁNS, USA. Los pacientes que experimentan confusión mental y otros síntomas duraderos de COVID-19 persistente muestran deficiencias significativas en las pruebas neuropsiquiátricas que se corresponden con una infección aguda previa por COVID-19, lo que se suma a la creciente evidencia del significativo costo que la afección crónica puede tener en la […]
Read More
A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus. Moderna released preliminary results on Wednesday on an updated coronavirus vaccine that targets the Omicron variant, calling it “our lead candidate” to serve as a U.S. booster […]
Read More
España La población de 0 a 19 años de edad suma un total de 9’219.654 personas, lo que representa 19,4% de la población total. La población del grupo de edad de 5 a 11 años es de 3’355.137, es decir, 7% de la población total, según el Instituto Nacional de Estadística (INE) de España. […]
Read More